Gabapentin
Gabapentin is an anticonvulsant used off-label for hot flashes and night sweats in menopause, particularly when hormone therapy is not an option.
How it works
Gabapentin's exact mechanism for reducing hot flashes is not fully understood, but it is thought to reduce central sensitization in the hypothalamus — the brain region responsible for temperature regulation. It is not FDA-approved for this indication, but NAMS includes it as a non-hormonal option with moderate evidence. Clinical trials show roughly 45–50% reduction in hot flash frequency compared to placebo's 25–30%, with benefit appearing within two to four weeks. It is often considered for breast cancer survivors and others for whom estrogen is contraindicated.
Gabapentin is typically started at a low dose and gradually increased to find the level that balances symptom relief with side effects. Drowsiness, dizziness, and unsteadiness are the most common side effects and tend to be dose-dependent — these are the primary reasons people discontinue it. Evening or nighttime dosing can use the drowsiness effect to advantage for sleep disruption related to night sweats.
How to track Gabapentin
- Hot flash frequency and severity before starting, to establish a baseline for measuring response.
- Night sweat episodes and their effect on sleep — gabapentin's sedating effect may improve sleep quality separately from hot flash reduction.
- Drowsiness, dizziness, and unsteadiness — the most common side effects, which are dose-dependent.
- Medication timing: when during the day you take it and whether side effects or symptom relief cluster around that time.
- Cognitive effects: some people notice brain fog or word-finding difficulty, particularly at higher doses.
- Log hot flash frequency and severity for one to two weeks before starting so you have a real pre-treatment baseline to compare against.
- Note the time you use each application — if drowsiness is a problem during the day, that pattern can inform a timing conversation with your physician.
- Rate dizziness and unsteadiness on a consistent scale whenever they occur; this data helps determine whether a dose adjustment is warranted.
- Track sleep separately from hot flashes — gabapentin's sedating effect may reduce night sweats and improve sleep through different pathways, and distinguishing them helps clarify what's driving any improvement.
- Do not stop gabapentin abruptly; if you are considering stopping, note the date you started the taper conversation with your physician.
Questions to ask your physician
- My pre-treatment baseline was [X] hot flashes per day. At [Y weeks] on gabapentin, my current daily average is [Z]. Does that response look typical for this stage?
- I've been logging drowsiness consistently at [time of day] — does that pattern suggest a dose timing adjustment?
- My dizziness log shows [frequency and severity] — is that within the expected range for my current dose?
- My sleep tracking shows [X] nights of disruption per week. Has the gabapentin had the expected impact on night sweats at this point?